be_ixf;ym_202409 d_30; ct_50

Latest Insights on LOGI

omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.
2022 stock predictions 5 Bold Predictions for 2022 and Beyond These will be the biggest growth themes for 2022.
Smucker Investors Dale Cooper That Hits The Spot Meme Caffeine Dreams: Smucker, Sandwiches & Space Sleuthing
by Joseph Hargett November 24, 2021 Great Stuff
Where Do Pies Go When They Die? Great Ones. 10:30 a.m. November 24. I’m entering the town of Great Stuff … five miles south of Wall Street, 12 miles west of the state line. And I’ve never seen so many earnings reports in my life… All I did was to come to earnings season, and […]
crypto dao constitution Crypto Powers the Largest Crowdfund Ever This could be the next big trend in crypto…
apple autonomous car Apple’s Big Plans for Our Autonomous Future The next must-have Apple product might not be a phone, but a car…

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

"I couldn’t believe it … in just 2 months, I made $298,506 on one stock – that’s a 24% gain!"

- John B.

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This